Copenhagen, Denmark – Amoment of great pride unfolded at The Union World Conference on Lung Health2025, where our CEO, Dr. Lou, delivered a highlyanticipated presentation to a full house. Hissession, "Synergistic TB Screening from Infection to Disease:Applications of AIMTB and AIMLAM," turned a spotlight on theinnovative products fueling the global belief of "Yes, wecan, End TB."
The audience,comprising a distinguished gathering of global health leaders and internationalexperts, listened with keen interest as Dr. Lou revealed a significantmilestone: highly encouraging results from recent internationalmulti-center evaluations of our novel diagnostic solutions. Thisdata, generated through successful collaborations with key internationalpartners, validates the strong performance and globalapplicability of our technology.
Beyond thesepromising validation results, Dr. Lou unveiled the latest groundbreakingadvancements across our product portfolio. The presentation made it clear thatour approach is not incremental, but truly innovative,offering a synergistic and powerful strategy to combat TB.